Q. Wang, F. Yang, Q. Miao, E. L. Krawitt, M. E. Gershwin et al., The clinical phenotypes of autoimmune hepatitis: a comprehensive review, J Autoimmun, vol.66, pp.98-107, 2016.

M. Sebode, J. Hartl, D. Vergani, and A. W. Lohse, Autoimmune hepatitis: from current knowledge and clinical practice to future research agenda, Liver Int, vol.38, pp.15-22, 2018.
DOI : 10.1111/liv.13458

M. P. Manns, A. J. Czaja, J. D. Gorham, E. L. Krawitt, G. Mieli-vergani et al., Diagnosis and management of autoimmune hepatitis, Hepatology, vol.51, pp.2193-213, 2010.

C. Schramm, C. Weiler-normann, C. Wiegard, S. Hellweg, S. Müller et al., Treatment response in patients with autoimmune hepatitis, Hepatology, vol.52, pp.2247-2248, 2010.

, European Association for the Study of the Liver. EASL clinical practice guidelines: autoimmune hepatitis, J Hepatol, vol.63, pp.971-1004, 2015.

M. A. Heneghan, A. D. Yeoman, S. Verma, A. D. Smith, and M. S. Longhi, Autoimmune hepatitis, Lancet, vol.382, pp.1433-1444, 2013.

B. Hoeroldt, E. Mcfarlane, A. Dube, P. Basumani, M. Karajeh et al., Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center, Gastroenterology, vol.140, pp.1980-1989, 2011.

R. Liberal, E. L. Krawitt, J. M. Vierling, M. P. Manns, G. Mieli-vergani et al., Cutting edge issues in autoimmune hepatitis, J Autoimmun, vol.75, pp.6-19, 2016.

M. S. Longhi, M. J. Hussain, R. R. Mitry, S. K. Arora, G. Mieli-vergani et al., Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis, J Immunol, vol.176, pp.4484-4491, 2006.

C. R. Grant, R. Liberal, B. S. Holder, J. Cardone, Y. Ma et al., Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis, Hepatology, vol.59, pp.1007-1015, 2014.

R. Liberal, C. R. Grant, M. Yuksel, J. Graham, A. Kalbasi et al., Treg conditioning endows activated Teff with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis, Hepatology, vol.66, 2017.
DOI : 10.1002/hep.29307

URL : https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.29307

R. Liberal, C. R. Grant, B. S. Holder, J. Cardone, M. Martinez-llordella et al., In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression, Hepatology, vol.62, pp.863-875, 2015.

M. Peiseler, M. Sebode, B. Franke, F. Wortmann, D. Schwinge et al., FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency, J Hepatol, vol.57, pp.125-132, 2012.
DOI : 10.1016/j.jhep.2012.02.029

R. Taubert, M. Hardtke-wolenski, F. Noyan, A. Wilms, A. K. Baumann et al., Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies, J Hepatol, vol.61, pp.1106-1114, 2014.
DOI : 10.1016/j.jhep.2014.05.034

S. Ferri, M. S. Longhi, D. Molo, C. Lalanne, C. Muratori et al., A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis, Hepatology, vol.52, pp.999-1007, 2010.

L. Ma, J. Qin, H. Ji, P. Zhao, and Y. Jiang, Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis, Liver Int, vol.34, pp.405-415, 2014.
DOI : 10.1111/liv.12245

N. Kimura, S. Yamagiwa, T. Sugano, T. Setsu, K. Tominaga et al., Possible involvement of CCR7(-) PD-1(+) follicular helper T cell subset in the pathogenesis of autoimmune hepatitis, J Gastroenterol Hepatol, vol.33, pp.298-306, 2018.

L. Zhao, Y. Tang, Z. You, Q. Wang, S. Liang et al., Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression, PLoS ONE, vol.6, p.18909, 2011.

Y. H. Oo, V. Banz, D. Kavanagh, E. Liaskou, D. R. Withers et al., CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver, J Hepatol, vol.57, pp.1044-1051, 2012.

E. M. Hennes, M. Zeniya, A. J. Czaja, A. Parés, G. N. Dalekos et al., Simplified criteria for the diagnosis of autoimmune hepatitis, Hepatology, vol.48, pp.169-176, 2008.

K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De-groote et al., Histological grading and staging of chronic hepatitis, J Hepatol, vol.22, pp.696-699, 1995.

M. Salou, B. Nicol, A. Garcia, D. Baron, L. Michel et al., phenotypic and functional analyses of mucosal associated invariant T cells in multiple sclerosis, Clin Immunol, pp.166-167, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02150108

T. Duhen and D. J. Campbell, IL-1? promotes the differentiation of polyfunctional human CCR6+CXCR3+ Th1/17 cells that are specific for pathogenic and commensal microbes, J Immunol, vol.193, pp.120-129, 2014.

A. Kurioka, L. J. Walker, P. Klenerman, and C. B. Willberg, MAIT cells: new guardians of the liver, Clin Transl Immunology, vol.5, p.98, 2016.

K. Böttcher, K. Rombouts, F. Saffioti, D. Roccarina, M. Rosselli et al., MAIT cells are chronically activated in patients with autoimmune liver disease and promote pro-fibrogenic hepatic stellate cell activation, Hepatology, 2018.

J. R. Fergusson, M. H. Hühn, L. Swadling, L. J. Walker, A. Kurioka et al., CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut, Mucosal Immunol, vol.9, pp.401-413, 2016.

M. Paroni, V. Maltese, D. Simone, M. Ranzani, V. Larghi et al., Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses, J Allergy Clin Immunol, vol.140, pp.797-808, 2017.

N. Serriari, M. Eoche, L. Lamotte, J. Lion, M. Fumery et al., Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases, Clin Exp Immunol, vol.176, pp.266-274, 2014.
DOI : 10.1111/cei.12277

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992039

I. Magalhaes, K. Pingris, C. Poitou, S. Bessoles, N. Venteclef et al., Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients, J Clin Invest, vol.125, pp.1752-1762, 2015.
DOI : 10.1172/jci78941

URL : http://www.jci.org/articles/view/78941/files/pdf

J. Hengst, B. Strunz, K. Deterding, H. Ljunggren, E. Leeansyah et al., Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy, Eur J Immunol, vol.46, pp.2204-2210, 2016.
DOI : 10.1002/eji.201646447

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.201646447

H. C. Jeffery, B. Van-wilgenburg, A. Kurioka, K. Parekh, K. Stirling et al., Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1, J Hepatol, vol.64, pp.1118-1127, 2016.
DOI : 10.1016/j.jhep.2015.12.017

URL : https://doi.org/10.1016/j.jhep.2015.12.017

A. R. Bonnel, C. Bunchorntavakul, and K. R. Reddy, Immune dysfunction and infections in patients with cirrhosis, Clin Gastroenterol Hepatol, vol.9, pp.727-738, 2011.
DOI : 10.1016/j.cgh.2011.02.031

Y. Gao and A. P. Williams, Role of innate T cells in anti-bacterial immunity, Front Immunol, vol.6, p.302, 2015.

D. G. Doherty, Immunity, tolerance and autoimmunity in the liver: a comprehensive review, J Autoimmun, vol.66, pp.60-75, 2016.

A. C. Cherñavsky, N. Paladino, A. E. Rubio, D. Biasio, M. B. Periolo et al., Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children, Hum Immunol, vol.65, pp.683-691, 2004.